<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2984705R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2786</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Res.</journal-id>
<journal-title-group>
<journal-title>Cancer research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0008-5472</issn>
<issn pub-type="epub">1538-7445</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27729325</article-id>
<article-id pub-id-type="pmc">5093024</article-id>
<article-id pub-id-type="doi">10.1158/0008-5472.CAN-16-0309</article-id>
<article-id pub-id-type="manuscript">NIHMS815418</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolite and microbiome interplay in cancer immunotherapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Caroline H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spilker</surname>
<given-names>Mary E.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goetz</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peterson</surname>
<given-names>Scott N.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Siuzdak</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520</aff>
<aff id="A2"><label>2</label>Pfizer Worldwide Research and Development, 10724 Science Center Dr, San Diego, CA 92121</aff>
<aff id="A3"><label>3</label>Department of Surgery, Scripps Clinic Medical Group, La Jolla, CA 92037</aff>
<aff id="A4"><label>4</label>Sanford Burnham Medical Research Institute, La Jolla, CA, 92037</aff>
<aff id="A5"><label>5</label>Scripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA 92037</aff>
<author-notes>
<corresp id="FN1">Corresponding Authors: Gary Siuzdak, Scripps Center for Metabolomics, The Scripps Research Institute, La Jolla, CA 92037. Tel: 858-784-9415, Fax: 858-784-9496, <email>siuzdak@scripps.edu</email>. Caroline Helen Johnson, Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520. Tel: 203-785-2734, Fax: 203-737-6023, <email>caroline.johnson@yale.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Conflict of interest</bold>
</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>76</volume>
<issue>21</issue>
<fpage>6146</fpage>
<lpage>6152</lpage>
<!--elocation-id from pubmed: 10.1158/0008-5472.CAN-16-0309-->
<abstract>
<p id="P1">The role of the host microbiome has come to the forefront as a potential modulator of cancer metabolism, and could be a future target for precision medicine. A recent study revealed that in colon cancer, bacteria form polysaccharide matrices called biofilms at a high frequency in the proximal colon. Comprehensive untargeted and stable isotope assisted metabolomic analysis revealed that the bacteria utilize polyamine metabolites produced from colon adenomas/carcinomas to build these protective biofilms, and may contribute to the inflammation and proliferation of colon cancer. This study highlighted the importance of finding the biological origin of a metabolite and assessing its metabolism and mechanism of action. This led to a better understanding of host and microbial interactions, thereby aiding therapeutic design for cancer. In this review we will discuss methodologies for identifying the biological origin and roles of metabolites in cancer progression, and discuss the interactions of the microbiome and metabolites in immunity and cancer treatment, focusing on the flourishing field of cancer immunotherapy.</p>
</abstract>
<kwd-group>
<kwd>Metabolomics</kwd>
<kwd>microbiome</kwd>
<kwd>cancer</kwd>
<kwd>immunotherapy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>